NKF-KDOQI Guidelines
The National Kidney Foundation has a well-deserved reputation for developing and implementing medical programs which have had a significant positive impact on improving outcomes for patients. These include clinical practice guidelines published under NKF’s KDOQI brand. Since 1997, we have published 22 guidelines on topics ranging from vascular access for dialysis patients to chronic kidney disease itself. We are proud of those guidelines and the way they have helped the kidney community, in addition to individual patients and medical professionals, make better informed decisions about improving care. All these guidelines followed the rigorous KDOQI process, were developed by independent volunteer work groups and were funded by more than a dozen companies within the kidney disease field. 
Clinical Practice Guidelines
Guideline Development and Methodology
Disclaimer and Acceptable Use Policy
Guiding Principles for Corporate Relationships (PDF* 40 KB)
National Kidney Foundation Advisory on KDOQI Clinical Practice Guidelines
Published KDOQI Guidelines
- Anemia in Chronic Kidney Disease
Click for more information
KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease, 2007 Update of Hemoglobin Target
American Journal of Kidney Diseases, September 2007 supplement
Development Sponsors: Amgen, Inc, Baxter Healthcare Corporation, Fresenius, USA, Inc., Genentech, Inc., and Watson Pharmaceuticals, Inc.
- Diabetes and Chronic Kidney Disease
Click for more information
Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease
American Journal of Kidney Diseases, February 2007 Supplement
Development Sponsors: Amgen and Keryx Pharmaceuticals
Implementation Sponsors: Novartis, Merck, Sanofi Aventis
(PDF Version 5.7 MB)
- Hemodialysis Adequacy
Click for more information
Clinical Practice Guidelines and Clinical Practice Recommendations for Hemodialysis Adequacy, Update 2006
American Journal of Kidney Diseases, July 2006 supplement
Development Sponsors: Amgen, Inc, Baxter Healthcare Corporation, Fresenius, USA, Inc., Genentech, Inc., and Watson Pharmaceuticals, Inc.
- Peritoneal Dialysis
Click for more information
Clinical Practice Guidelines and Clinical Practice Recommendations for Peritoneal Dialysis Adequacy, Update 2006
American Journal of Kidney Diseases, July 2006 supplement
Development Sponsors: Amgen, Inc, Baxter Healthcare Corporation, Fresenius, USA, Inc., Genentech, Inc., and Watson Pharmaceuticals, Inc.
- Vascular Access
Click for more information
Clinical Practice Guidelines and Clinical Practice Recommendations for Vascular Access, Update 2006
American Journal of Kidney Diseases, July 2006 supplement
Development Sponsors: Amgen, Inc, Baxter Healthcare Corporation, Fresenius, USA, Inc., Genentech, Inc., and Watson Pharmaceuticals, Inc.
- Anemia Management
Click for more information
Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease
American Journal of Kidney Diseases, May 2006 supplement
Implementation Sponsors: Amgen and Roche Laboratories Inc.
- Nutrition
Click for more information
Clinical Practice Guidelines for Nutrition in Chronic Renal Failure
American Journal of Kidney Diseases, June 2000
Primary Sponsor: Sigma Tau
Sponsor: Baxter Healthcare, Fresenius USA
Associate Sponsor: Luitpold Pharmaceuticals (American Regent)
Implementation Sponsor: Watson Pharmaceuticals
- Chronic Kidney Disease: Evaluation, Classification, and Stratification
Click for more information
Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation Classification and Stratification
American Journal of Kidney Diseases, February 2002
Primary Sponsor: Amgen
Implementation Sponsors: Bayer Diagnostics, OrthoBiotech Products, LP, UpToDate
- Dyslipidemia
Click for more information
Clinical Practice Guidelines for Managing Dyslipidemias in Chronic Kidney Disease
American Journal of Kidney Diseases, April 2003
Primary Sponsor: Fujisawa
- Bone Metabolism and Disease in Chronic Kidney Disease
Click for more information
Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease
American Journal of Kidney Diseases, October 2004
Primary Sponsor: Abbott Laboratories
Associate Sponsors: Amgen, Genzyme
Implementation Sponsors: Abbott Laboratories, Amgen, Bone Care International, Genzyme, Shire US
- Bone Metabolism and Disease in Chronic Kidney Disease in Children
Click for more information
Clinical Practice Guidelines for Bone Metabolism and Disease in Children With Chronic Kidney Disease
Primary Sponsor: Abbott Laboratories
Associate Sponsors: Amgen, Genzyme
- Hypertension and Antihypertensive Agents in Chronic Kidney Disease
Click for more information
Clinical Practice Guidelines on Hypertension and Antihypertensive Agents in Chronic Kidney Disease
American Journal of Kidney Diseases, May 2004
Primary Sponsor: Astra Zeneca
Implementation Sponsor: Merck & Co., Inc
- Cardiovascular Disease in Dialysis Patients
Click for more information
Clinical Practice Guidelines for Cardiovascular Disease in Dialysis Patients
American Journal of Kidney Diseases, April 2005 supplement
Primary Sponsor: Satellite Healthcare
Implementation Sponsor: Genzyme
Translated Guidelines
- Russian
- Arabic*
* The National Kidney Foundation thanks Yousef BOOBES, MD, Head, Nephrology Division, Tawam Hospital, Al Ain, Abu Dhabi, UAE for the translation of these guidelines.
*PDF files require Adobe Acrobat Reader 
